Evidence map›Paper›PMID 34045216›Full record

ArticleBMJ open2021

COVID-19 and perinatal intimate partner violence: a cross-sectional survey of pregnant and postpartum individuals in the early stages of the COVID-19 pandemic.

Katherine A Muldoon, Kathryn M Denize, Robert Talarico, Carlie Boisvert, Olivia Frank, Alysha L J Harvey, Ruth Rennicks White, Deshayne B Fell, Meagan Ann O'Hare-Gordon, Yanfang Guo and 6 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 4 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 4 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Review
  8. Review
  9. The Impact of COVID-19 Pandemic on Intimate Partner Violence (IPV) Against Women.International journal of social determinants of health and health services · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Katherine A MuldoonClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada kmuldoon@ohri.ca.ORCID 0000-0002-0766-4294
Kathryn M DenizeClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Robert TalaricoClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Carlie BoisvertClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Olivia FrankClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Alysha L J HarveyClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Ruth Rennicks WhiteClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Deshayne B FellSchool of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Meagan Ann O'Hare-GordonClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Yanfang GuoClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0003-4749-2033
Malia S Q MurphyClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Daniel J CorsiClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0001-7063-3354
Kari SampselClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Shi Wu WenClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0002-7227-0283
Mark C WalkerClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Darine El-ChaarClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0002-8266-0242
Ottawa Hospital · CAUniversity of Ottawa · CAChildren's Hospital of Eastern Ontario · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe objectives of this study were to: (1) document violent and controlling behaviours within intimate partnerships during the perinatal period; and (2) determine individual, interpersonal and household-level factors influencing the risk of perinatal intimate partner violence (IPV).

designCross-sectional survey.

settingThe Ottawa Hospital, Department of Obstetrics and Gynecology, Ottawa, Ontario, Canada.

participantsPatients who gave birth at The Ottawa Hospital and were >20 days post partum between 17 March and 16 June 2020. MAIN OUTCOMES AND MEASURES: Perinatal IPV was defined as regular controlling behaviours or act-based forms of emotional/physical/sexual abuse in the 12 months before pregnancy, during pregnancy and/or post partum. Log-binomial multivariable regression models were used to compute adjusted risk ratios (aRRs) and 95% CIs to identify potential risk factors for IPV: maternal age, postpartum depression, parity, increase in partner substance use and household income.

resultsAmong 216 participants, the median maternal age was 33 years (IQR: 30-36). In total, 52 (24.07%) reported some form of perinatal IPV, 37 (17.13%) reported regular controlling behaviour and 9 (4.17%) reported both. Household income below the municipal median was the strongest risk factor for perinatal IPV (aRR: 3.24, 95% CI: 1.87 to 5.59). There was no apparent association between maternal age (aRR: 0.99, 95% CI: 0.94 to 1.04), postpartum depression (aRR: 1.03, 95% CI: 1.00 to 1.07), nulliparity (aRR: 1.18, 95% CI: 0.71 to 1.97) or increases in partner substance use (aRR: 0.73, 95% CI: 0.42 to 1.25) with IPV.

conclusionOne in four individuals in this study experienced perinatal IPV. Household income was the strongest risk factor, and surprisingly, many hypothesised risk factors (eg, mental health, partner substance use, etc) were not significantly associated with perinatal IPV in this sample. This highlights the challenges in both measuring IPV and identifying individuals exposed to perinatal IPV during the high stress of the COVID-19 pandemic.

Indexed as

COVID-19Intimate Partner ViolenceAdultCross-Sectional StudiesFemaleHumansOntarioPandemicsPostpartum PeriodPregnancyPrevalenceRisk FactorsSARS-CoV-2COVID-19maternal medicineobstetricspublic healthsocial medicine

Identifiers

PMID34045216
PMCPMC8728372
OpenAlexW3165582276

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.